gemcitabine has been researched along with pk 11195 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Adams, AL; Gallo, JM; Guo, P; Guo, Z; Li, S; Ma, J | 1 |
2 other study(ies) available for gemcitabine and pk 11195
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model.
Topics: Animals; Antimetabolites, Antineoplastic; Brain Neoplasms; Deoxycytidine; Drug Delivery Systems; Gemcitabine; Glioma; Humans; Isoquinolines; Male; Rats; Rats, Nude; Rats, Sprague-Dawley; Receptors, GABA-A; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |